Death is an inevitable reality. Throughout our lives, each of us will experience the deaths of loved ones and confront our own mortality. Given our role as healthcare providers, pharmacists frequently care for people who are dying, and we are trained to approach these patients with compassion and empathy while maintaining our clinical objectivity. Nonetheless, discussions about death continue to be excruciatingly difficult for patients, their families and friends, and healthcare professionals. Over the past 50 years—with the work of Elisabeth Kübler-Ross, the emergence of modern hospice care, establishment of patients’ and surrogates’ legal rights to refuse life-sustaining treatments, approval of the Patient Self-Determination Act of 1990, and passage of Death with Dignity laws—there has been more open dialogue about dying and death in society.1 In particular, over the past 20 years, beginning with the passage of Oregon’s first Death with Dignity referendum in 1994 and the subsequent U.S. Supreme Court rulings on the issue,2 the nation has been forced to engage, often with deep disagreements, in conversations surrounding end-of-life issues. Throughout this time frame, ASHP has provided a forum for these debates, and the pages of AJHP have included numerous articles on terminally ill patients’ decisions to end their lives with the support of the healthcare team. Last year, ASHP Councils, the ASHP House of Delegates, and the ASHP Board of Directors initiated a comprehensive and deliberative process to shape existing ASHP policy into a position on pharmacists’ participation in medical aid in dying.
Read full abstract